Advertisement
Home Tags Cancer: Colon

Tag: Cancer: Colon

Fecal immunochemical testing has advantages as a colorectal cancer screening method

Advantages of FIT As CRC Screening Method Discussed

FIT has several advantages over gFOBT, but practical concerns should be considered
Healthy living can lower the odds for colorectal cancer for men who are at high genetic risk for the disease

Men With Genetic Risk of CRC May Lower Risk Via Healthy Lifestyle

Adopting healthy lifestyle can cut 25-year risk for the disease from 29 to 13 percent
For patients with early-stage colorectal cancer

Metabolic Syndrome and Obesity Up Risk of Mortality in CRC

Obese patients with metabolic syndrome have increased risk of all-cause, CRC-related death
The American Academy of Family Physicians has graded the recommendation for colorectal cancer screening as a B recommendation

AAFP Downgrades USPSTF CRC Screening Recommendation

AAFP recommends fecal immunochemical tests, flexible sigmoidoscopy, colonoscopy
An intervention involving bilingual/bicultural lay health educator education can increase colorectal cancer screening among Hmong-Americans

Tailored Lay Health Educator Program Ups CRC Screening

Bilingual/bicultural lay health educator education can increase screening among Hmong-Americans
Retinoic acid might have a role in suppressing colorectal cancer

Retinoic Acid May Help Prevent, Treat Colorectal Cancer

Researchers are studying connection between retinoic acid and inflammation in gut
Colorectal cancer patients who consume higher amounts of omega-3 polyunsaturated fatty acids

Intake of Marine ω-3 PUFAs Tied to Colorectal Cancer Survival

High intake after CRC diagnosis associated with lower risk of CRC-specific mortality
A considerable proportion of older patients are not up-to-date with colorectal cancer screening and do not receive timely follow-up of abnormal fecal blood tests

Follow-Up of Colorectal CA Screens Lacking in Older Patients

Likelihood of being up-to-date, receiving timely follow-up lower for patients aged 76 years and older
Detection of circulating tumor DNA after resection of stage II colon cancer may identify patients at increased risk of recurrence

Circulating Tumor DNA May Help Predict Colon CA Recurrence

Findings in patients after resection of stage II colon cancer
The 12-gene Recurrence Score assay is valid for stage II and III colon cancer without chemotherapy

12-Gene Recurrence Score Valid in Colon Cancer Without Chemo

After adjustment for disease stage, continuous Recurrence Score linked to recurrence-free interval